Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
about
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stageDense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentricPioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathologyExogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice.The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.Effects of hypoperfusion in Alzheimer's disease.Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.A turning point for Alzheimer's disease?Secondary histomorphological changes in cerebral arteries of normotensive and hypertensive rats following a carotid-jugular fistula induction.Hypertension and cognitive functionAlzheimer's disease is a vasocognopathy: a new term to describe its nature.Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies.Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease.Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1The Alzheimer's disease beta-secretase enzyme, BACE1.Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.How do heart disease and stroke become risk factors for Alzheimer's disease?Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variationsThe Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of AgingDementia, stroke, and vascular risk factors; a review.Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies.Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study.Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease.Galactose counteracts hypoglycemia-induced decline of cholinergic neurons at low pH in organotypic rat brain slices of the basal nucleus of Meynert.Vascular risk factors: a ticking time bomb to Alzheimer's disease.The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study.Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.A unifying hypothesis of Alzheimer's disease. III. Risk factors.Taking the pulse of aging: mapping pulse pressure and elasticity in cerebral arteries with optical methods.Contributors to white matter damage in the frontal lobe in Alzheimer's disease.Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex.Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis.
P2860
Q27500371-2D82C565-BC7D-469B-96A5-94890109F885Q28216994-D16E5D0E-81CD-45E1-90C7-CD87D3A5A70DQ28594423-3BDC990E-C3AD-4E32-8A75-D5A2DB130222Q30640089-FA7A663D-9C5B-4E45-8423-B3D3CC9ADA02Q30830414-42C694CF-5E32-4928-803C-14FB99AB044DQ33610745-F014C62D-96CB-481A-B8BB-605B624137BBQ34039966-F9AAA132-47F7-4DE1-A2DB-D2CA73077645Q34042902-0F3F6755-D123-4220-8773-2C978E672027Q34066200-6A34E6EF-A1B1-42BC-8741-77ED972B743FQ34197623-A3A510A3-B9AE-435A-9800-A83AB17B7FF3Q35125134-EFDD8BA7-E41D-41C7-B1F0-1D81B23DDD96Q35178724-D45FAD48-9E80-4A9D-BEB6-59E07F605952Q35841706-E166C6BC-4AF2-4C95-8134-C20145BA31FDQ35953789-651E1583-572E-4995-937F-7F2FE44B1163Q36194290-54FCEED3-1A86-4541-9F75-A609C56DACB2Q36375702-B8A06822-801F-4E27-8E6C-212ED2C77494Q36397690-260BA8FA-1BAD-4F6E-8226-2A7BCC6CC1ACQ36455581-00E5FA77-F92F-4B3F-9666-64BF34709D35Q36582784-CD376E80-EC1C-4D8E-A6AC-A7E9596F3A21Q36795245-E6F983F7-E011-4B83-A8B7-385CB74154EDQ37108142-54C2CEC6-22EA-4E31-B31D-996F1667209DQ37419640-C2A9BDC9-9553-4AF7-900A-A4765248BBCAQ37970511-C8E60CF7-A1F0-4F07-AFE5-5422E2D6DC92Q39024557-C055C2EA-C1E6-4F79-B43C-2C8686E874D9Q40077982-CAB085C6-1C2F-41A9-A325-1F165659CFCAQ40292275-BBB5462E-0A5D-4239-9F4F-41C2DD1C5406Q42495933-67E0FA2D-081B-46D1-84D8-4DB67734F3B4Q43499916-F1270C9E-B2DF-43DC-BB4D-13DB71317D79Q43693957-2FC86DD0-5CBD-459B-BE7D-E9ECD0750EBAQ45259615-B0563150-2ECE-4C62-B23C-3D03A67D9C33Q47300836-CAC7ABB9-1773-4A9D-A758-802DA57C252BQ48458709-4D663595-B997-42C9-BB48-AA57B5C27E68Q48617587-7D020BBF-CAF1-42A5-B418-5E69321F3387Q48700189-33D260D4-D975-4A0E-8DD4-360786BA6677Q48883966-DD1ECB11-E294-4E1E-A26E-8AACC2222C00Q53375401-0FAB89B8-2B61-4A59-A19D-25365EBA42C4
P2860
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@ast
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@en
type
label
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@ast
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@en
prefLabel
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@ast
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@en
P356
P1476
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
@en
P2093
de la Torre JC
P2888
P356
10.1007/S004010051044
P577
1999-07-01T00:00:00Z
P6179
1038109853